Search alternatives:
processing algorithm » modeling algorithm (Expand Search), routing algorithm (Expand Search), tracking algorithm (Expand Search)
method algorithm » network algorithm (Expand Search), means algorithm (Expand Search), mean algorithm (Expand Search)
elements method » element method (Expand Search)
data processing » image processing (Expand Search)
code algorithm » cosine algorithm (Expand Search), novel algorithm (Expand Search), modbo algorithm (Expand Search)
data code » data model (Expand Search), data came (Expand Search)
processing algorithm » modeling algorithm (Expand Search), routing algorithm (Expand Search), tracking algorithm (Expand Search)
method algorithm » network algorithm (Expand Search), means algorithm (Expand Search), mean algorithm (Expand Search)
elements method » element method (Expand Search)
data processing » image processing (Expand Search)
code algorithm » cosine algorithm (Expand Search), novel algorithm (Expand Search), modbo algorithm (Expand Search)
data code » data model (Expand Search), data came (Expand Search)
-
4521
Image 2_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.tif
Published 2025“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”
-
4522
Table 5_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.xlsx
Published 2025“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”
-
4523
Image 3_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.tif
Published 2025“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”
-
4524
Image1_Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients.TIF
Published 2024“…Background<p>Melanoma, a malignant tumor of the skin, presents challenges in its treatment process involving modalities such as surgery, chemotherapy, and targeted therapy. …”
-
4525
Table 2_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.xlsx
Published 2025“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”
-
4526
Image 1_Validation of the Somnolyzer 24×7 automatic scoring system in children with suspected obstructive sleep apnea.tif
Published 2025“…Introduction<p>Manual scoring of polysomnography data is a laborious and complex process. Automatic scoring by current computer algorithms shows high agreement with manual scoring. …”
-
4527
Table 1_Validation of the Somnolyzer 24×7 automatic scoring system in children with suspected obstructive sleep apnea.docx
Published 2025“…Introduction<p>Manual scoring of polysomnography data is a laborious and complex process. Automatic scoring by current computer algorithms shows high agreement with manual scoring. …”
-
4528
Table 6_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.xlsx
Published 2025“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”
-
4529
Table 1_Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma.docx
Published 2025“…</p>Methods<p>The transcriptomic data from 230 plasma exosomes and 831 HCC tissues were integrated. …”
-
4530
Image 6_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4531
Table 1_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.xlsx
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4532
Image 4_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4533
Image 7_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4534
Image 9_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4535
Image 2_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4536
Image 10_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4537
Image 1_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4538
Image 3_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4539
Image 5_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”
-
4540
Image 8_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif
Published 2025“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”